Alrubicin 150mg Injection
By Alrubicin
Rx
1 Injection in a Vial

Composition
Epirubicin(150mg)

Manufacturer - Alkem Laboratories Ltd
Alkem Laboratories Limited, Devashish Building, Alkem House, Senapati Bapat Road, Lower Parel, Mumbai - 400 013.

Expires on or after
July, 2025

liver
When taking Alrubicin 150mg Injection, it's important to be cautious if you have liver disease. You may need a dose adjustment, so make sure to talk to your doctor about this. It's best not to use Alrubicin 150mg Injection if you have severe liver disease. Always seek guidance from your doctor to ensure your safety and well-being while using this medication.

kidney
Alrubicin 150mg Injection is likely safe for patients with kidney disease. Consult your doctor about the need for dose adjustment. Consider lower doses if serum creatinine > 5 mg/dL.

alcohol
It is important to avoid drinking alcohol while using Alrubicin 150mg Injection as it is considered unsafe to mix the two.

driving
Alrubicin 150mg Injection may affect driving ability due to side effects like nausea and vomiting. It can temporarily impair focus and reaction time, so caution is advised while driving.

pregnancy
Alrubicin 150mg Injection is considered unsafe during pregnancy due to the risk it poses to the developing baby. In certain life-threatening situations, a doctor may prescribe it if the benefits outweigh the risks. Please consult your doctor before using.

breastfeeding
Alrubicin 150mg Injection is not safe to use while breastfeeding. It can be harmful to the baby due to potential toxicity.
Habit Forming | No |
Chemical Class | Anthracycline Derivative |
Therapeutic Class | - |
Action Class | Alkaloids-cytotoxic agents |
₹2903
Inclusive of all taxes
Content verified by

Dr. Abdullah Khan
MBBS - General Medicine
Last update on 11-Feb-2025